Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients

Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén and Anders Bjartell
Journal of Nuclear Medicine May 2020, 61 (5) 671-675; DOI: https://doi.org/10.2967/jnumed.119.231100
Aseem Anand
1Division of Urological Cancers, Department of Translational Medicine, Skåne University Hospital, Lund University, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elin Trägårdh
2Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Edenbrandt
3Department of Nuclear Medicine, Gothenburg University, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Beckman
4Department of Oncology, Sundsvall-Härnösand County Hospital, Sundsvall, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Henry Svensson
5Department of Urology, Skövde Hospital, Skövde, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camilla Thellenberg
6Department of Radiation Sciences, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Widmark
6Department of Radiation Sciences, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Kindblom
7Department of Oncology, Gothenburg University, Gothenburg, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Ullén
8Department of Oncology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Bjartell
1Division of Urological Cancers, Department of Translational Medicine, Skåne University Hospital, Lund University, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 5 671-675
DOI 
https://doi.org/10.2967/jnumed.119.231100
PubMed 
31586004

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 20, 2019
  • Accepted for publication September 16, 2019
  • Published online May 1, 2020.

Article Versions

  • previous version (October 4, 2019 - 13:09).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Aseem Anand1,
  2. Elin Trägårdh2,
  3. Lars Edenbrandt3,
  4. Lars Beckman4,
  5. Jan-Henry Svensson†,5,
  6. Camilla Thellenberg6,
  7. Anders Widmark6,
  8. Jon Kindblom7,
  9. Anders Ullén8 and
  10. Anders Bjartell1
  1. 1Division of Urological Cancers, Department of Translational Medicine, Skåne University Hospital, Lund University, Malmö, Sweden
  2. 2Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden
  3. 3Department of Nuclear Medicine, Gothenburg University, Gothenburg, Sweden
  4. 4Department of Oncology, Sundsvall-Härnösand County Hospital, Sundsvall, Sweden
  5. 5Department of Urology, Skövde Hospital, Skövde, Sweden
  6. 6Department of Radiation Sciences, Umeå University, Umeå, Sweden
  7. 7Department of Oncology, Gothenburg University, Gothenburg, Sweden; and
  8. 8Department of Oncology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
  1. For correspondence or reprints contact: Anders Bjartell, Skåne University Hospital, Jan Waldenströmsgat 5, 20502 Malmö, Sweden. E-mail: anders.bjartell{at}med.lu.se
View Full Text

Statistics from Altmetric.com

Cited By...

  • 15 Citations
  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair
    Zacharenia Nikitaki, Anastasia Velalopoulou, Vassiliki Zanni, Ioanna Tremi, Sophia Havaki, Michael Kokkoris, Vassilis G. Gorgoulis, Constantinos Koumenis, Alexandros G. Georgakilas
    Expert Reviews in Molecular Medicine 2022 24
  • Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
    Daniela E. Oprea-Lager, Matthijs C.F. Cysouw, Ronald Boellaard, Christophe M. Deroose, Lioe-Fee de Geus-Oei, Egesta Lopci, Luc Bidaut, Ken Herrmann, Laure S. Fournier, Tobias Bäuerle, Nandita M. deSouza, Frederic E. Lecouvet
    Frontiers in Oncology 2021 11
  • Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial
    Kazuhiro Kitajima, Masataka Igeta, Junpei Kuyama, Takashi Kawahara, Tsuyoshi Suga, Tomoaki Otani, Shigeyasu Sugawara, Yumiko Kono, Yukihisa Tamaki, Ayumi Seko-Nitta, Yoshinobu Ishiwata, Kimiteru Ito, Akira Toriihara, Shiro Watanabe, Makoto Hosono, Hideaki Miyake, Shingo Yamamoto, Mitsuhiro Narita, Takashi Daimon, Koichiro Yamakado
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 5
  • Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study
    Anniina Hyväkkä, Okko‐Sakari Kääriäinen, Tapio Utriainen, Eliisa Löyttyniemi, Kalle Mattila, Petri Reinikainen, Jorma Sormunen, Minna Jääskeläinen, Päivi Auvinen, Heikki Minn, Maria Sundvall
    Cancer Medicine 2023 12 4
  • Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial
    Kazuhiro Kitajima, Junpei Kuyama, Takashi Kawahara, Tsuyoshi Suga, Tomoaki Otani, Shigeyasu Sugawara, Yumiko Kono, Yukihisa Tamaki, Ayumi Seko-Nitta, Yoshinobu Ishiwata, Kimiteru Ito, Akira Toriihara, Shiro Watanabe, Makoto Hosono, Hideaki Miyake, Shingo Yamamoto, Ryohei Sasaki, Mitsuhiro Narita, Koichiro Yamakado
    Cancers 2023 15 10
  • Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
    Yasuhide Miyoshi, Sohgo Tsutsumi, Takashi Kawahara, Masato Yasui, Koichi Uemura, Shuko Yoneyama, Yumiko Yokomizo, Narihiko Hayashi, Masahiro Yao, Hiroji Uemura
    BJUI Compass 2021 2 1
  • A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide
    D.P. Petrylak, U.N. Vaishampayan, K.R. Patel, C.S. Higano, C. Albany, N.A. Dawson, B.A. Mehlhaff, D.I. Quinn, L.T. Nordquist, V.J. Wagner, J. Siegel, L. Trandafir, O. Sartor
    ESMO Open 2021 6 2
  • Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases
    Hisashi Hirano, Masayoshi Nagata, Naoya Nagaya, So Nakamura, Takeshi Ashizawa, Yan Lu, Haruna Kawano, Kosuke Kitamura, Yoshiro Sakamoto, Kazuhiko Fujita, Hideyuki Isobe, Akira Tsujimura, Satoru Muto, Shigeo Horie
    Scientific Reports 2023 13 1
  • Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer
    Joe M. O’Sullivan, Rana R. McKay, Kambiz Rahbar, Karim Fizazi, Daniel J. George, Bertrand Tombal, Anja Schmall, Per Sandström, Frank Verholen, Neal Shore
    Frontiers in Medicine 2022 9
  • Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
    Stephan Probst, Anders Bjartell, Aseem Anand, Tayna Skamene, Cristiano Ferrario
    Nuclear Medicine and Molecular Imaging 2022 56 4

Article usage

Article usage: October 2019 to April 2025

AbstractFullPdf
Oct 20198860105
Nov 2019174037
Dec 2019131029
Jan 2020111026
Feb 2020102011
Mar 202082010
Apr 202098016
May 20209442078
Jun 2020252527
Jul 2020101117
Aug 20209736
Sep 2020108520
Oct 202073416
Nov 2020641523
Dec 2020481817
Jan 2021433325
Feb 2021452623
Mar 2021332729
Apr 2021312514
May 2021243016
Jun 2021163013
Jul 2021282822
Aug 2021211723
Sep 2021143019
Oct 2021235535
Nov 2021422232
Dec 2021243021
Jan 2022291314
Feb 2022322119
Mar 2022211320
Apr 2022211717
May 2022172220
Jun 20222188
Jul 202212259
Aug 2022191116
Sep 2022131618
Oct 20221697
Nov 2022281618
Dec 202293616
Jan 2023142616
Feb 2023121912
Mar 202318128
Apr 202312911
May 202312713
Jun 2023131414
Jul 2023151719
Aug 202319911
Sep 2023171216
Oct 2023252833
Nov 202352116
Dec 2023173111
Jan 2024152111
Feb 20246408
Mar 202481740
Apr 202443321
May 2024103718
Jun 2024164020
Jul 202463112
Aug 2024123514
Sep 202432311
Oct 2024111411
Nov 202431918
Dec 202413158
Jan 20253147
Feb 2025188020
Mar 202585324
Apr 2025222029
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (5)
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén, Anders Bjartell
Journal of Nuclear Medicine May 2020, 61 (5) 671-675; DOI: 10.2967/jnumed.119.231100

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén, Anders Bjartell
Journal of Nuclear Medicine May 2020, 61 (5) 671-675; DOI: 10.2967/jnumed.119.231100
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Rediscovering the indispensable role of FDG PET in kidney cancer imaging
  • The role of FDG PET/CT in clinical evaluation and management of nasopharyngeal carcinoma
  • Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • automated bone scan index (aBSI)
  • imaging biomarker
  • bone scan
  • 223Ra
  • mCRPC
SNMMI

© 2025 SNMMI

Powered by HighWire